Understanding the complex spatial and temporal process by which tumors initiate, evolve and respond to therapy is a major focus of the oncology community and one that requires the integration of multiple disciplines. A diverse suite of therapies have been developed in the modern era, leading to significantly improved survival rates across many cancers. However, many treatments share a cycle of short-term success followed by recurrence, often of a more aggressive tumor. In the past decade, the cancer research community has begun to acknowledge the importance of heterogeneity across genotypic, phenotypic, and environmental scales as a key driver in drug resistance and treatment failure. The intricate dialogue between tumor cells and environment selects for clones that are best adapted phenotypically to survive, regardless of specific mutations that may facilitate tumor progression. These dynamics, occurring between a heterogeneous tumor and a heterogeneous environment (the cancer ecosystem) are almost impossible to dissect experimentally. Further, adding multiple treatments to the mix often leads to nonlinear and unintuitive dynamics. Therefore, understanding how tumor evolution and ecology changes with treatment is key to controlling the emergence of aggressive and resistant clones following therapy. Our central hypothesis here is that when treating cancer we should exploit heterogeneity, rather than ignore it, by developing crowdsourced sequential and combination therapies that steer tumor evolution and ecology producing more effective, less toxic and longer lasting responses. We plan to test this hypothesis through the development of a research game based on treating a heterogeneous evolving cancer. The core engine of the game will be a calibrated mathematical model of solid tumor growth, tailored to specific organ sites through different associated tumor phenotypes, environment and treatment options. Based on patterns observed while interacting with our research game, successful players will choose the follow-up treatments based on an understanding of the cancer's adaptive response to previous treatments as well as how the cancer is responding to the current therapy in real time. As a result of the power of crowdsourced computation and human intelligence we will derive a suite of optimal treatment strategies across a diverse set of cancer ecosystems.

Public Health Relevance

Crowdsourcing optimal cancer treatment strategies that maximize efficacy and minimize toxicity Heterogeneity in cancer is observed across many biological scales. This heterogeneity generates evolutionary and ecological forces that promote cancer cell resistance to therapy. Here we propose to develop a multiscale model of this complex heterogeneity in cancer and turn it into a treatment game that, through the power of crowdsourced computation, will predict smarter and more effective treatment strategies. Our central hypothesis is that when treating cancer we should exploit heterogeneity, rather than ignore it, by developing crowdsourced sequential and combination therapies that steer tumor evolution and ecology producing more effective, less toxic and longer lasting responses.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Exploratory/Developmental Cooperative Agreement Phase I (UH2)
Project #
5UH2CA203781-02
Application #
9254517
Study Section
Special Emphasis Panel (ZRG1-BST-U (50)R)
Program Officer
Miller, David J
Project Start
2016-04-05
Project End
2018-03-31
Budget Start
2017-04-01
Budget End
2018-03-31
Support Year
2
Fiscal Year
2017
Total Cost
$265,995
Indirect Cost
$56,873
Name
H. Lee Moffitt Cancer Center & Research Institute
Department
Type
Research Institutes
DUNS #
139301956
City
Tampa
State
FL
Country
United States
Zip Code
33612
Kim, Eunjung; Rebecca, Vito W; Smalley, Keiran S M et al. (2016) Phase i trials in melanoma: A framework to translate preclinical findings to the clinic. Eur J Cancer 67:213-222